A large body of evidence indicates that genetic mutations, epigenetic changes, chronic
inflammation, diet, and lifestyle are key risk factors for colorectal cancer (CRC). Prevention of …

Substantial efforts are underway for prevention of early stages or recurrence of colorectal
cancers (CRC) or new polyp formation by chemoprevention strategies. Several …

Colorectal cancer (CRC) is the second most common fatal malignancy in the Western world,
with more than 150,000 new cases accounting for 55,000 deaths in the United States every …

Colorectal cancer (CRC) is one of the most common human malignancies and a leading
cause of cancer-related deaths in developed countries. Identifying effective preventive …

Colorectal cancer (CRC) is a serious yet preventable disease. The low acceptance and cost
of colonoscopy as a screening method for CRC make chemoprevention an important option …

Simple Summary Non-steroidal anti-inflammatory drugs prevent the recurrence of
adenomatous polyps and colon cancer. At low doses, with presumed low gastrotoxicity …

Colorectal cancer is the third most incident cancer in the United States and is second only to
lung cancer as a cause of cancer-related mortality. Colorectal cancer develops through a …

Every year more than a million new cancer cases and 600,000 deaths are reported world-
wide. Colorectal cancer is the fourth most commonly occurring and second leading cause of …

Non‐steroidal anti‐inflammatory drugs are chemopreventive agents in colorectal cancer.
Non‐steroidal anti‐inflammatory drugs do not, however, offer complete protection against …

BACKGROUND & AIMS: Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) lower
the risk of colorectal cancer (CRC). We investigated whether plasma inflammatory markers …